Naphthalenyl derivatives for hitting P-gp/MRP1/BCRP transporters

被引:24
作者
Colabufo, Nicola A. [1 ]
Contino, Marialessandra [1 ]
Cantore, Mariangela [1 ,2 ]
Capparelli, Elena [1 ]
Perrone, Maria Grazia [1 ]
Cassano, Giuseppe [3 ]
Gasparre, Giuseppe [3 ]
Leopoldo, Marcello [1 ]
Berardi, Francesco [1 ]
Perrone, Roberto [1 ]
机构
[1] Univ Bari ALDO MORO, Dipartimento Farm, I-70125 Bari, Italy
[2] Natl Canc Inst, Clin Expt Oncol Lab, I-70124 Bari, Italy
[3] Univ Bari ALDO MORO, Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, I-70125 Bari, Italy
关键词
P-glycoprotein; Naphthalenyl derivatives; BCRP; MRP1; MDR revertant agents; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; CANCER; INHIBITORS; MRP1; BCRP; RADIOTRACER; MODULATION; DESIGN; ASSAYS;
D O I
10.1016/j.bmc.2012.12.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substituted naphthalenyl derivatives bearing oxazole, or thiazole or furyl heteronuclei have been carried out as bioisosters of aryl-oxazoles and -thiazoles derivatives previously reported in order to investigate the role of the hindrance on the activity towards P-gp/BCRP/and MRP1 transporters. In addition, the role of naphthalenyl group to modulate P-gp intrinsic activity of these compounds was ascertained. The results demonstrated that all naphthalenyl derivatives displayed comparable P-gp activity with respect to lead compounds previously characterized in our SAR studies but were less active towards BCRP and MRP1 pumps. In terms of intrinsic activity, the replacement of aryl with naphthalenyl moiety led to P-gp inhibitors, unambiguous or ambiguous substrates on the base of the heteronucleus and the substituent on the naphthalenyl fragment. Indeed, oxazole derivatives were: inhibitors (R = H, F, OH), unambiguous substrates (R = OCH3), or ambiguous substrate (R = Br); thiazole derivatives were: unambiguous substrates (R = OCH3, Br), or ambiguous substrates (R = H, F). Finally furyl derivatives were ambiguous substrates. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1324 / 1332
页数:9
相关论文
共 29 条
  • [1] ALTENBERG GA, 1994, J BIOL CHEM, V269, P7145
  • [2] Inhibitors of multidrug resistance to antitumor agents (MDR)
    Avendaño, C
    Menéndez, JC
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (02) : 159 - 193
  • [3] Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor
    Bauer, Florian
    Kuntner, Claudia
    Bankstahl, Jens P.
    Wanek, Thomas
    Bankstahl, Marion
    Stanek, Johann
    Mairinger, Severin
    Doerner, Bernd
    Loescher, Wolfgang
    Mueller, Markus
    Erker, Thomas
    Langer, Oliver
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (15) : 5489 - 5497
  • [4] A family of drug transporters: The multidrug resistance-associated proteins
    Borst, P
    Evers, R
    Kool, M
    Wijnholds, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16): : 1295 - 1302
  • [5] Multi-Drug-Resistance-Reverting Agents: 2-Aryloxazole and 2-Arylthiazole Derivatives as Potent BCRP or MRP1 Inhibitors
    Colabufo, Nicola A.
    Berardi, Francesco
    Perrone, Maria Grazia
    Cantore, Mariangela
    Contino, Marialessandra
    Inglese, Carmela
    Niso, Mauro
    Perrone, Roberto
    [J]. CHEMMEDCHEM, 2009, 4 (02) : 188 - 195
  • [6] Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives
    Colabufo, Nicola Antonio
    Berardi, Francesco
    Cantore, Mariangela
    Perrone, Maria Grazia
    Contino, Marialessandra
    Inglese, Carmela
    Niso, Mauro
    Perrone, Roberto
    Azzariti, Amalia
    Simone, Grazia Maria
    Porcelli, Letizia
    Paradiso, Angelo
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (01) : 362 - 373
  • [7] Colabufo NA, 2010, CURR TOP MED CHEM, V10, P1701
  • [8] Synthesis and Small-Animal Positron Emission Tomography Evaluation of [11C]-Elacridar As a Radiotracer to Assess the Distribution of P-Glycoprotein at the Blood-Brain Barrier
    Doerner, Bernd
    Kuntner, Claudia
    Bankstahl, Jens P.
    Bankstahl, Marion
    Stanek, Johann
    Wanek, Thomas
    Stundner, Gloria
    Mairinger, Severin
    Loescher, Wolfgang
    Mueller, Markus
    Langer, Oliver
    Erker, Thomas
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (19) : 6073 - 6082
  • [9] Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
    Doyle, LA
    Ross, DD
    [J]. ONCOGENE, 2003, 22 (47) : 7340 - 7358
  • [10] EIDELMAN O, 1989, METHOD ENZYMOL, V172, P122